Brief: Inhalerx Has Received Firm Commitments For A$1.2M Share Placement
Sept 19 (Reuters) - Inhalerx Ltd IRX.AX :
* HAS RECEIVED FIRM COMMITMENTS FOR A$1.2M SHARE PLACEMENT
* ISSUE AT A$0.06 PER SHARE
* FUNDS RAISED TO BE USED FOR REGULATORY WORK REQUIRED WITH
FDA,
TO SUPPORT DRUG, DEVICE DEVELOPMENT FOR USE IN CO'S TWO CLINICAL
PROGRAMMES
Source text for Eikon: ID:nASX7nx1ZW
Further company coverage: IRX.AX
Recent news on Nexalis Therapeutics
See all newsBrief: Nexalis Therapeutics Says Sean Williams Has Resigned As Non-Executive Chairman
Brief: Nexalis Therapeutics Signs Funding Partnership With Point8 Capital To Replace Existing Facility
Brief: Nexalis Therapeutics Seeks Trading Halt
Brief: Nexalis Therapeutics Says US Policy Market Advancement Supports SRX-25 TRD Treatment
Australia's Nexalis Therapeutics gains most in over 6 months on trial approval